- Home
- TLSI vs RITR Comparison
TLSI vs RITR Comparison
Compare TLSI & RITR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TLSI
- RITR
- Stock Information
- Founded
- TLSI 2010
- RITR 2015
- Country
- TLSI United States
- RITR Hong Kong
- Employees
- TLSI N/A
- RITR N/A
- Industry
- TLSI Medical Specialities
- RITR
- Sector
- TLSI Health Care
- RITR
- Exchange
- TLSI Nasdaq
- RITR NYSE
- Market Cap
- TLSI 204.0M
- RITR 221.1M
- IPO Year
- TLSI N/A
- RITR 2024
- Fundamental
- Price
- TLSI $5.54
- RITR $5.24
- Analyst Decision
- TLSI Strong Buy
- RITR
- Analyst Count
- TLSI 5
- RITR 0
- Target Price
- TLSI $10.90
- RITR N/A
- AVG Volume (30 Days)
- TLSI 39.7K
- RITR 713.4K
- Earning Date
- TLSI 08-13-2025
- RITR 02-15-2025
- Dividend Yield
- TLSI N/A
- RITR N/A
- EPS Growth
- TLSI N/A
- RITR N/A
- EPS
- TLSI N/A
- RITR 0.09
- Revenue
- TLSI $32,141,000.00
- RITR $47,948,887.00
- Revenue This Year
- TLSI $55.52
- RITR N/A
- Revenue Next Year
- TLSI $54.76
- RITR N/A
- P/E Ratio
- TLSI N/A
- RITR $60.73
- Revenue Growth
- TLSI 46.20
- RITR 278.44
- 52 Week Low
- TLSI $3.50
- RITR $2.24
- 52 Week High
- TLSI $6.08
- RITR $8.75
- Technical
- Relative Strength Index (RSI)
- TLSI 53.07
- RITR N/A
- Support Level
- TLSI $5.18
- RITR N/A
- Resistance Level
- TLSI $5.54
- RITR N/A
- Average True Range (ATR)
- TLSI 0.32
- RITR 0.00
- MACD
- TLSI 0.01
- RITR 0.00
- Stochastic Oscillator
- TLSI 82.81
- RITR 0.00
About TLSI TriSalus Life Sciences Inc.
TriSalus Life Sciences Inc is engaged in the research, development, and sales of drug delivery technology and immune-oncology therapeutics to improve outcomes in difficult-to-treat liver and pancreatic cancer. It is developing and marketing two product linesPressure Enabled Drug Delivery (PEDD) infusion systems, in use today, and an investigational agent, nelitolimod (SD-101), which shows potential to enhance immune system response in the treatment of hepatocellular cancer, pancreatic cancer and other liver solid tumors. TriNav is the newest therapy delivery device with SmartValve technology for the proprietary PEDD approach.
About RITR REITAR LOGTECH HLDGS LTD
Reitar Logtech Holdings Ltd provide one-stop solutions for logistics property operations in property development and redevelopment projects. It consists of two segments: construction management and engineering design services; and asset management and professional consultancy services in Hong Kong. Key revenue is generated from construction management and engineering design services.